A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma

1. Sepúlveda, J.M.
2. Belda-Iniesta, C.
3. Gil-Gil, M.
4. Pérez-Segura, P.
5. Berrocal, A.
6. Reynés, G.
7. Gallego, O.
8. Capellades, J.
9. Ordoñez, J.M.
10. La Orden, B.
11. Balañá, C.